Can a stronger radiation dose save the rectum? new trial aims to find out.

NCT ID NCT04095299

Recruiting now Disease control Sponsor: Vejle Hospital Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 21 times

Summary

This study is for people with early-stage rectal cancer who would normally need surgery. It compares standard radiation doses to higher doses, both given with chemotherapy. The goal is to see if the higher dose helps more people achieve a complete response, allowing them to avoid surgery and keep their rectum. About 162 participants will be followed for two years to measure success.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER OF RECTUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aalborg University Hospital
RECRUITING

Aalborg, Denmark
Copenhagen University Hospital, Righshospitalet and Bispebjerg Hospital
RECRUITING

Copenhagen, Denmark
Department of Oncology, Vejle Hospital
RECRUITING

Vejle, Denmark

Contact Email: •••••@•••••
Zealand University Hospital, Næstved
RECRUITING

Næstved, Denmark
Zealand University Hospital, Roskilde
RECRUITING

Roskilde, Denmark

Conditions

Explore the condition pages connected to this study.

CANCER OF RECTUM